Iliac vein stenting in a patient with lower extremity swelling resulting from diffuse pelvic mass: A case report

Tadayon, Niki; Zarrintan, Sina; Hosseini, Seyed Masoud; Kalantar-Motamedi, Seyed Mohammad Reza

doi:10.34172/jcvtr.2020.57

Cited by 3 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Malignant tumors can compress or invade the adjacent iliac veins, resulting in stenosis or occlusion. Types of malignancies, involved veins, and their management are summarized in Table 1 [ 1 , 2 , 5 , 6 , 8 , 10 - 13 ]. Different kinds of pelvic malignancies, including bladder, prostate, ovarian, cervical, endometrial, and retroperitoneal cancers, can cause venous obstruction.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Iliofemoral Vein Stenting in a Patient with Pelvic Metastasis

Zarrintan

Yavari

Tadayon

et al. 2021

Vasc Specialist Int

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…The presenting symptoms were related to the location and severity of the mass. Tadayon et al [ 11 ] reported a patient with papillary urothelial carcinoma of the bladder that recurred and extended to the right EIV. The patient was treated using a 12×80-mm venous stent.…”

Section: Discussionmentioning

confidence: 99%

Iliofemoral Vein Stenting in a Patient with Pelvic Metastasis

Zarrintan

Yavari

Tadayon

et al. 2021

Vasc Specialist Int

Self Cite

View full text Add to dashboard Cite

show abstract

Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression

Aly,

Moussa,

Chevallier

et al. 2024

CVIR Endovasc

View full text Add to dashboard Cite

Background Cancer patients with pelviabdominal masses can suffer from lower extremity symptoms due to venous compression. The effectiveness of venous stenting has been established in extrinsic venous compression in benign conditions like May-Thurner syndrome. In this retrospective study we evaluate the efficacy and safety of caval, iliocaval and iliofemoral venous stenting for cases of extrinsic venous compression caused by malignant masses in cancer patients. Methods IRB-approved retrospective review of patients who underwent iliofemoral venography with venoplasty and stenting between January 2018 and February 2022 was performed. Patients with extrinsic venous compression caused by malignant masses were included. Data on patient demographics, pre-procedure symptoms, procedural technique, stent characteristics, outcomes and follow-up were collected. Descriptive statistics were used to assess technical success, clinical success, primary stent patency and adverse events of the procedure. Results Thirty-seven patients (19 males, 18 females) who underwent 45 procedures were included. Deep venous thrombosis (DVT) was present in 21 (57%) patients. Twenty-nine patients (78%, 95% CI 62–90%) reported clinical improvement of the presenting symptoms. The median overall survival after the procedure was 4.7 months (95% CI 3.58–5.99). Eight (22%) patients were alive at last follow up with median follow up of 10.33 months (Range 2–25 months). Twenty-six patients had patent stents on their last follow up imaging (70%, 95% CI 61%-91%). Two patients had a small access site hematoma which resolved spontaneously. Two patients developed moderate, and 1 patient developed severe adverse events related to post procedure therapeutic anticoagulation. Conclusion Venous stenting is a safe procedure and should be considered as part of the palliative care for patients with debilitating lower extremity symptoms related to iliocaval and iliofemoral venous compression. Graphical Abstract

show abstract

Iliocaval and Iliofemoral Venous Stenting for Obstruction Secondary to Tumor Compression: Single Center Experience

Aly,

Moussa,

Chevallier

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Cancer patients with pelviabdominal masses can suffer from lower extremity symptoms due to venous compression. The effectiveness of venous stenting has been established in extrinsic venous compression in benign conditions like May-Thurner syndrome. In this retrospective study we evaluate the efficacy and safety of caval, iliocaval and iliofemoral venous stenting for cases of extrinsic venous compression caused by malignant masses in cancer patients. Methods IRB-approved retrospective review of patients who underwent iliofemoral venography with venoplasty and stenting between January 2018 and February 2022 was performed. Patients with extrinsic venous compression caused by malignant masses were included. Data on patient demographics, pre-procedure symptoms, procedural technique, stent characteristics, outcomes and follow-up were collected. Descriptive statistics were used to assess technical success, clinical success, primary stent patency and adverse events of the procedure. Results Thirty-seven patients (19 males, 18 females) who underwent 45 procedures were included. Deep venous thrombosis (DVT) was present in 21 (57%) patients. Twenty-nine patients (78%, 95% CI 62-90%) reported clinical improvement of the presenting symptoms. The median overall survival after the procedure was 4.7 months (95% CI 3.58-5.99). Eight (22%) patients were alive at last follow up with median follow up of 10.33 months (Range 2-25 months). Twenty-six patients had patent stents on their last follow up imaging (70%, 95% CI 61%-91%). Two patients had a small access site hematoma which resolved spontaneously. Two patients developed moderate, and 1 patient developed severe adverse events related to post procedure therapeutic anticoagulation Conclusion Venous stenting is a safe procedure and should be considered as part of the palliative care for patients with debilitating lower extremity symptoms related to iliocaval and iliofemoral venous compression.

show abstract

Iliac vein stenting in a patient with lower extremity swelling resulting from diffuse pelvic mass: A case report

Cited by 3 publications

References 9 publications

Iliofemoral Vein Stenting in a Patient with Pelvic Metastasis

Iliofemoral Vein Stenting in a Patient with Pelvic Metastasis

Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression

Iliocaval and Iliofemoral Venous Stenting for Obstruction Secondary to Tumor Compression: Single Center Experience

Contact Info

Product

Resources

About